Enzymic Transesterification for OPO Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for producing 1,3-dioleoyl-2-palmitoyl glyceride (OPO) are inefficient, and there is a need for a more effective method to match the chemical and physical properties of human milk fat, particularly in infant formulas, as existing methods struggle with achieving the optimal distribution of fatty acid residues in triglycerides.
Innovation Solution
A process involving enzymic transesterification of palm oil stearin with an iodine value between 8 and 12 using oleic acid or its ester, followed by separation and dry fractionation to increase the OPO content, while minimizing other triglycerides like PPP and OOO, and maximizing palmitic acid residues in the 2-position.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional enzymatic processes are used to produce OPO, then some OPO is formed, but the process is inefficient and fails to achieve optimal distribution of fatty acid residues
Solution Approach 1:
The process uses a two-stage enzymatic approach: first a 1,3-specific lipase creates ABA triglycerides with palmitic acid at positions 1 and 3, then a 1,2,3-specific lipase converts these to OPO by replacing the fatty acids at positions 1 and 3 with oleic acid. This segmentation of the conversion process into distinct stages with different enzyme specificities enables efficient OPO production with controlled fatty acid distribution.
Solution Approach 2:
Instead of directly converting PPP to OPO in a single step, the process inverts the approach by first creating an intermediate ABA structure and then converting to OPO. This indirect route through ABA triglycerides as an intermediate allows better control over the final OPO formation and improves overall process efficiency.
2Quantity of substance
If vegetable oils are used to create fat compositions with similar fatty acid amounts to human milk fat, then the fatty acid composition matches, but the glyceride position distribution remains unsaturated at the 2-position unlike human milk fat
Solution Approach 1:
The process specifically targets the 2-position of the glyceride backbone to ensure palmitic acid occupies this position, while allowing unsaturated fatty acids at positions 1 and 3. The enzymatic reactions are designed with position-specific selectivity: the 1,3-specific lipase acts only on positions 1 and 3, while the 1,2,3-specific lipase subsequently modifies all three positions, ensuring palmitic acid is concentrated at the 2-position to match human milk fat structure.
3Manufacturing precision
If multiple enzymatic conversion steps are used to reduce trisaturates, then OPO purity improves, but the process complexity and time increase
Solution Approach 1:
The process employs continuous enzymatic action through sequentially added enzymes that work in a coordinated manner. The 1,3-specific lipase continuously produces ABA intermediates, which are then continuously converted by the 1,2,3-specific lipase to OPO. This continuous multi-enzyme action achieves high OPO purity and reduces trisaturates effectively while maintaining process efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process significantly increases the OPO content in the product, enhancing the nutritional quality and matching the fatty acid distribution of human milk fat, with the OPO composition achieving a higher SN-2 value, thereby improving the digestibility and emulsification properties of the resulting fat composition.
Implementation Method 1
subjecting a palm oil stearin, with an iodine value (IV) between 8 and 12 to enzymic transesterification, with oleic acid or a non-glyceride ester thereof
Data Source
AI summary
A process for the production of a composition comprising l,3-dioleyl-2-palmitoyl glyceride (OPO) comprises subjecting a palm oil stearin, with an iodine value (IV) between about 2 and about 12 to enzymic transesterification, with oleic acid or a non-glyceride ester thereof.